William Blair Investment Management LLC Acquires 84,394 Shares of UnitedHealth Group Incorporated $UNH

William Blair Investment Management LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.3% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 768,535 shares of the healthcare conglomerate’s stock after acquiring an additional 84,394 shares during the quarter. UnitedHealth Group makes up 0.7% of William Blair Investment Management LLC’s holdings, making the stock its 26th biggest holding. William Blair Investment Management LLC’s holdings in UnitedHealth Group were worth $265,375,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. New Age Alpha Advisors LLC boosted its holdings in shares of UnitedHealth Group by 3.6% in the 3rd quarter. New Age Alpha Advisors LLC now owns 36,827 shares of the healthcare conglomerate’s stock worth $12,716,000 after purchasing an additional 1,269 shares during the period. Sierra Summit Advisors LLC increased its position in UnitedHealth Group by 161.4% during the third quarter. Sierra Summit Advisors LLC now owns 6,587 shares of the healthcare conglomerate’s stock valued at $2,274,000 after acquiring an additional 4,067 shares during the last quarter. Strategies Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 94.1% during the 3rd quarter. Strategies Wealth Advisors LLC now owns 2,186 shares of the healthcare conglomerate’s stock worth $755,000 after purchasing an additional 1,060 shares during the period. Aprio Wealth Management LLC raised its position in UnitedHealth Group by 3.4% in the 3rd quarter. Aprio Wealth Management LLC now owns 2,085 shares of the healthcare conglomerate’s stock worth $720,000 after purchasing an additional 69 shares during the period. Finally, Aviso Financial Inc. boosted its position in shares of UnitedHealth Group by 0.6% during the third quarter. Aviso Financial Inc. now owns 12,875 shares of the healthcare conglomerate’s stock valued at $4,446,000 after buying an additional 73 shares during the period. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on UNH. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Mizuho lowered their target price on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research note on Thursday, February 5th. Jefferies Financial Group lowered their price objective on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Finally, Evercore upgraded UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Stock Up 2.2%

Shares of NYSE UNH opened at $292.97 on Friday. The stock has a market capitalization of $265.38 billion, a PE ratio of 22.21, a price-to-earnings-growth ratio of 1.35 and a beta of 0.41. The company has a current ratio of 0.79, a quick ratio of 0.82 and a debt-to-equity ratio of 0.72. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $606.36. The stock’s fifty day simple moving average is $311.98 and its two-hundred day simple moving average is $325.90.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. The firm had revenue of $113.73 billion during the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm’s quarterly revenue was up 12.3% on a year-over-year basis. During the same period in the prior year, the business posted $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend is Monday, March 9th. UnitedHealth Group’s payout ratio is currently 67.02%.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Board affirms quarterly cash dividend of $2.21/share (record March 9, payable March 17), which supports income investors and signals steady capital return policy. Dividend Steady as Margins Tighten Might Change The Case For Investing In UnitedHealth Group (UNH)
• Positive Sentiment: Market reaction: reports show UNH trading materially higher after the dividend announcement, indicating short-term buying interest tied to the payout confirmation. UnitedHealth Group (NYSE:UNH) Trading 3.7% Higher Following Dividend Announcement
• Positive Sentiment: Relative strength vs. peers: analysts argue UNH’s scale and diversified model give it better upside versus Humana as managed-care margins are tested, supporting a longer-term constructive view. UnitedHealth vs. Humana: Which Healthcare Stock Has More Upside Now?
• Neutral Sentiment: Sector flows: some strategists recommend rotating into defensive names and healthcare, which could provide tailwinds for UNH even as the macro outlook weakens. Time for Investors to Get Defensive. Sell Staples and Buy Healthcare.
• Negative Sentiment: Guidance and margin pressure: coverage highlights weaker 2026 revenue guidance and rising medical costs (especially Medicare-related), which compress margins and are a key reason for investor caution. Dividend Steady as Margins Tighten Might Change The Case For Investing In UnitedHealth Group (UNH)
• Negative Sentiment: Institutional selling: Aristotle Growth Equity Fund exited its UNH position citing lowered guidance — a signal some funds are trimming exposure ahead of margin headwinds. Aristotle Growth Equity Fund Exited UnitedHealth Group (UNH) Due to Lowered Guidance
• Negative Sentiment: Recent price weakness and re-rating: commentary notes a sizable multi-month share-price decline and that UNH is down since the last earnings report, underscoring investor concerns about near-term earnings and margin recovery. Is It Time To Reassess UnitedHealth Group (UNH) After A 37% Share Price Slide?

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.